About ceribell inc. - CBLL
Ceribell, Inc. is a commercial-stage medical technology company, which focuses on transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.
CBLL At a Glance
Ceribell, Inc.
360 North Pastoria Avenue
Sunnyvale, California 94085
| Phone | 1-800-436-0826 | Revenue | 45.23M | |
| Industry | Medical Specialties | Net Income | -29,464,000.00 | |
| Sector | Health Technology | 2023 Sales Growth | 74.466% | |
| Fiscal Year-end | 12 / 2024 | Employees | 229 | |
| View SEC Filings |
CBLL Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | N/A |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | N/A |
CBLL Efficiency
| Revenue/Employee | 197,489.083 |
| Income Per Employee | -128,663.755 |
| Receivables Turnover | 5.685 |
| Total Asset Turnover | 0.622 |
CBLL Liquidity
| Current Ratio | 2.336 |
| Quick Ratio | 2.064 |
| Cash Ratio | 1.597 |
CBLL Profitability
| Gross Margin | 84.385 |
| Operating Margin | -66.426 |
| Pretax Margin | -65.125 |
| Net Margin | -65.15 |
| Return on Assets | -40.534 |
| Return on Equity | -61.272 |
| Return on Total Capital | -59.687 |
| Return on Invested Capital | -52.175 |
CBLL Capital Structure
| Total Debt to Total Equity | 40.398 |
| Total Debt to Total Capital | 28.774 |
| Total Debt to Total Assets | 24.106 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 3.397 |